HALO logo
halo search icon
Hoth Therapeutics, Inc.

US$0.60

Price Change Indicator
-0.0001 (-0.017%)
Hoth Therapeutics, Inc.
HOTH · NAS

Hoth Therapeutics, Inc.

Start Trading HOTH for Free

US$0.60

Price Arrow-0.0001 (-0.017%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Hoth Therapeutics, Inc. Overview

HOTH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About HOTH

icon
icon

Telephone

1.646.756.2997

icon

Address

Suite 5066, 5th floor, 1177 Avenue of the Americas, New York, NY 10036

Description

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.

HOTH Price Chart

Key Stats

Market Cap

US$11.48M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.49 - 2.12

Trade Value (12mth)

US$350,890.00

1 week

-5.21%

1 month

-19.99%

YTD

-43.93%

1 year

-28.14%

All time high

347.00

Key Fundamentals

EPS 3 yr Growth

-90.50%

EBITDA Margin

0.00%

Operating Cashflow

-$10m

Free Cash Flow Return

-150.50%

ROIC

-191.40%

Interest Coverage

0.00

Quick Ratio

4.70

Other Data

Shares Outstanding (Fully Diluted)

16m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HOTH Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
07 May 26
07 May 26
07 May 26

HOTH Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.38-1.28-0.9locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.38-1.28-0.9locklocklock
Growth
 %locklocklocklock754629.7locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Hoth Therapeutics, Inc. (HOTH:NAS)?
Halo FAQ
The current share price of Hoth Therapeutics, Inc. (HOTH:NAS) is USD$0.60.
What is the 52-week high share price for Hoth Therapeutics, Inc. (HOTH:NAS)?
Halo FAQ
The 52-week high share price for Hoth Therapeutics, Inc. (HOTH:NAS) is USD$2.12.
What is the 52-week low share price for Hoth Therapeutics, Inc. (HOTH:NAS)?
Halo FAQ
The 52-week low share price for Hoth Therapeutics, Inc. (HOTH:NAS) is USD$0.49.
What is the dividend yield for Hoth Therapeutics, Inc. (HOTH:NAS)?
Halo FAQ
Hoth Therapeutics, Inc. (HOTH:NAS) does not pay a dividend.
What was Hoth Therapeutics, Inc. (HOTH:NAS) last dividend payment?
Halo FAQ
Hoth Therapeutics, Inc. (HOTH:NAS) does not pay a dividend.
What is the franking level for Hoth Therapeutics, Inc. (HOTH:NAS)?
Halo FAQ
Hoth Therapeutics, Inc. (HOTH:NAS) has a franking level of 0.00%.
In which sector is Hoth Therapeutics, Inc. (HOTH:NAS) classified?
Halo FAQ
Hoth Therapeutics, Inc. (HOTH:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial